Alka-seltzer thorn. tab., # 10
Category
Alcoholism
Scope of the medicinal product
General
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
ten
Amount in a package
ten
Dosage form
soluble tablets
Manufacturer
Bayer Pharma AG, Germany
Structure
1 effervescent tablet contains:
acetylsalicylic acid 325 mg
sodium bicarbonate 1625 mg
citric acid 965 mg.
pharmachologic effect
Alka-Seltzer has analgesic, anti-inflammatory, antipyretic, antiaggregatory effects.
Inactivates cyclooxygenase, disrupts the synthesis of PG, prostacyclins and thromboxane.
Bicarbonate neutralizes free hydrochloric acid in the stomach, reducing the likelihood of NSAID gastropathy.
Indications
Headache,
gastrointestinal discomfort
heartburn,
general malaise.
Application during pregnancy and lactation
It is advisable for children and adolescents to prescribe Alka-Seltzer only if other drugs are ineffective.
Alka-Seltzer During pregnancy, Alka-Seltzer is contraindicated.
During breastfeeding, when taken in medium doses, interruption of breastfeeding is usually not required.
With regular intake of high doses of Alka-Seltzer, the issue of stopping breastfeeding should be resolved.
Contraindications
chronic or recurring symptoms of nausea, stomach pain
renal dysfunction
increased tendency to bleed
bronchial asthma.
Side effects
nausea, lack of appetite, pain in the stomach, gastrointestinal bleeding
allergic reactions
decrease in platelets in the blood.
Interaction
Reduces the effect of anti-gout drugs (including side effects), enhances anticoagulants and oral hypoglycemic drugs, NSAIDs, side effects of methotrexate.
How to take, course and dosage
for adults, a single dose - 1-2 tab, daily dose - up to 8 tab.
For children over 3 years old, a single dose is 0.5-1.5 tab.
daily dose - 1-4 tab.
Overdose
Symptoms
Moderate overdose: nausea, vomiting, tinnitus, hearing impairment, headache, dizziness and confusion.
These symptoms disappear when the dose of the drug is reduced.
4 Severe overdose: fever, hyperventilation, ketosis, respiratory alkalosis, metabolic acidosis, coma, cardiogenic shock, respiratory failure, severe hypoglycemia.
Treatment: hospitalization, lavage, intake of activated charcoal, monitoring of acid-base balance, alkaline diuresis in order to obtain urine pH between 7.5-8 (forced alkaline diuresis is considered achieved if the concentration of salicylates in plasma is more than 500 mg / l ( 3.6 mmol / L) in adults or 300 mg / L (2.2 mmol / L) in children), hemodialysis, fluid replacement, symptomatic therapy
Special instructions
Alka-Seltzer should be used with caution in patients with bronchial asthma, allergies, as well as in patients with hypersensitivity to painkillers and anti-inflammatory drugs.
Release form
Effervescent tablets.
Round, flat white tablets, engraved on one side ALKA SELTZER" in a convex circle protruding along the perimeter.
The reverse side is chamfered.
2 effervescent tablets in a strip of paper laminated with aluminum foil
1, 3, 5, 6 or 10 strips with instructions for use in a cardboard box
Storage conditions
At a temperature not exceeding 25 ° C
Shelf life
3 years
Brand name
ALKA-SELTZER
Active substance
Acetylsalicylic acid, Citric acid, Sodium bicarbonate
Terms of dispensing from pharmacies
Without recipe
Name ENG
ALKA SELTZER
Clinical and pharmacological group
NSAIDs
ATX code
Acetylsalicylic acid in combination with other drugs (excluding psycholeptics)
Dosage
324mg + 965mg + 1.625g
Structure
1 effervescent tablet contains: acetylsalicylic acid 325 mg.
sodium bicarbonate 1625 mg.
citric acid 965 mg.
Indications
Symptomatic treatment of pain syndrome of mild to moderate severity: headache (including after alcohol consumption), toothache, sore throat, pain in the back and muscles, joint pain,
pain during menstruation, increased body temperature with colds and other infectious and inflammatory diseases (in adults and children over 15 years old).
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Contraindications
Hypersensitivity to acetylsalicylic acid and other NSAIDs or other components of the drug
erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase)
hemorrhagic diathesis
the combined use of methotrexate at a dose of 15 mg per week or more
complete and incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses and intolerance to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (including in history)
pregnancy (I and III trimester), breastfeeding period.
the drug is not prescribed to children under 15 years of age with acute respiratory diseases caused by viral infections, due to the risk of developing Reye's syndrome 3 (encephalopathy and acute fatty degeneration of the liver with acute development of liver failure).
INN / Active ingredient
Acetylsalicylic acid + citric acid + sodium bicarbonate
Specifications
Category
Alcoholism
Scope of the medicinal product
General
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
ten
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Alka-seltzer
The amount of the dosage form in the primary package
2 pcs.
Primary packaging type
Cell-free contoured packaging (strip)
Type of consumer packaging
Pack of cardboard
Dosage form
Effervescent tablets
The target audience
Children
Expiration date in days
1095
Package weight, g
thirty
Mode of application
:
for adults, a single dose - 1-2 tab, daily dose - up to 8 tab.
< br> For children over 3 years old, a single dose - 0.5-1.5 tab. < br> a daily dose - 1-4 tab.
Pharmaco-therapeutic group
:
Combined analgesic (NSAID + antacid)
Anatomical and therapeutic characteristics
:
N02BA51 Acetylsalicylic acid, in combination with other drugs (excluding psychotropic drugs)
Dosage (volume) of the substance in the preparation
:
acetylsalicylic acid 325 mg sodium bicarbonate 1625 mg citric acid 965 mg
Information on technical characteristics, delivery set, country of manufacture "